NCT01873053View on ClinicalTrials.gov

A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

August 31, 2014

Conditions
Osteoarthritis, Knee
Interventions
DRUG

WIN-34B

Patients assigned to Experimental group(1st or 2nd group) take WIN-34B 450mg or WIN-34B 900mg BID for 12weeks

DRUG

Placebo

Trial Locations (1)

134-727

Kyung Hee University Oriental Medicine Hospital at Gangdong, Seoul

Sponsors
All Listed Sponsors
collaborator

Kyung Hee University Hospital at Gangdong

OTHER

collaborator

Hamsoa Pharmaceutical Co., Ltd.

INDUSTRY

lead

Kyunghee University Medical Center

OTHER